Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Balanag · SciRah

Researcher profile · Semantic Scholar

V. Balanag

Share profile

V. Balanag — researcher profile on SciRah

h-index: 7
Works: 13
Citations: 371

Most-cited papers

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
F. vonGroote-Bidlingmaier, R. Patientia, E. Sánchez, V. Balanag +19 more
2019The Lancet Respiratory Medicine121 citations Open access
Semantic Scholar
Treatment Strategy for Rifampin-Susceptible Tuberculosis
N. Paton, C. Cousins, Celina Suresh, Erlina Burhan +17 more
2023New England Journal of Medicine109 citations Open access
Semantic Scholar
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
C. Tweed, G. Wills, A. Crook, E. Amukoye +35 more
2021The International Journal of Tuberculosis and Lung Disease55 citations Open access
Semantic Scholar
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
M. Cevik, Lindsay C Thompson, C. Upton, V. Rolla +32 more
2024Lancet. Infectious Diseases (Print)39 citations Open access
Semantic Scholar
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.
G. Cross, Intan P. Sari, C. Kityo, Qing-Shu Lu +13 more
2023Lancet. Infectious Diseases (Print)24 citations
Semantic Scholar
Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial
Nicholas I. Paton, C. Cousins, Intan P. Sari, Erlina Burhan +17 more
2025Lancet. Infectious Diseases (Print)9 citations
Semantic Scholar
PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment
G. Cross, Intan P. Sari, Sarah M Burkill, C. W. Yap +10 more
2024Nature Communications7 citations Open access
Semantic Scholar
Introduction of bedaquiline for the treatment of drug-resistant TB in the Philippines.
M. R. Santiago, A. C. Garfin, V. Balanag
2020The International Journal of Tuberculosis and Lung Disease5 citations Open access
Semantic Scholar
Effectiveness and Safety of 9-Month Treatment Regimen for Multidrug-Resistant Tuberculosis in the Philippines
V. Lofranco, V. Balanag, Lawrence O. Raymond, N. Macalalad +3 more
2022Journal of Tuberculosis Research3 citations Open access
Semantic Scholar
Interim Outcomes and Adverse Events among Drug-Resistant Tuberculosis Patients Treated with Bedaquiline in the Philippines
V. Lofranco, Maria Rhoda A. Torres-Cervas, Katherine A. Asence, Khrizza Marianne A. Del Mundo +3 more
2022Journal of Tuberculosis Research1 citations Open access
Semantic Scholar
A Partially-Randomised Phase 3 Trial of Pretomanid, Moxifloxacin and Pyrazinamide in Combination for the Treatment of Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis
C. Tweed, G. Wills, A. Crook, E. Amukoye +35 more
20201 citations
Semantic Scholar
The Introduction of Bedaquiline Regimen for Drug-Resistant Tuberculosis in the Philippines: An Operational Study
V. Balanag, V. Lofranco, M. Mantala, M. Santiago +3 more
2022Journal of Tuberculosis Research0 citations Open access
Semantic Scholar
The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB
Augusto Sablan, J. Gonong, L. Raymond, V. Lofranco +1 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Variava×4
Invite
E. Variava — researcher profile on SciRah
J. Caoili×4
Invite
J. Caoili — researcher profile on SciRah
S. Staples×4
Invite
S. Staples — researcher profile on SciRah
Victoria B. Dalay×4
Invite
Victoria B. Dalay — researcher profile on SciRah

×4

Invite

A. Nunn — researcher profile on SciRah

Invite

V. Lofranco — researcher profile on SciRah

Invite

Qing-Shu Lu — researcher profile on SciRah

Invite

F. Conradie — researcher profile on SciRah

Invite

R. Hunt — researcher profile on SciRah

Invite

C. Louw — researcher profile on SciRah

M. Malahleha×3

Invite

M. Malahleha — researcher profile on SciRah

Intan P. Sari×3

Invite

Intan P. Sari — researcher profile on SciRah